跳至主要内容
临床试验/TCTR20240527005
TCTR20240527005招募中不适用

Incidence of symptomatic meibomian gland dysfunction and characteristics of meibomian gland after cataract surgery

Chulalongkorn university0 个研究点目标入组 77 人开始时间: 2024年5月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
77

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1.Able to read, understand and sign an informed consent form
  • 2.Able and willing to comply with the follow-up schedule and requirements
  • 3.Patients diagnosed with cataracts with an indication for cataract surgery

排除标准

  • 1.Preexisting symptomatic meibomian gland dysfunction
  • 2.Complicated cataract surgery
  • 3.Other ocular surface diseases
  • 4.Patients who had used artificial tears within the past 1 week or topical medication to treat another ocular disease or systemic drugs that were known to affect the tear film and ocular surface
  • 5.History of lid spa in the past 1 week
  • 6.History of ocular trauma, ocular surgery, and ocular infection in the past 3 months, except for those causing permanent damage to the ocular surface
  • 7.Contact lens wearer
  • 8.Pregnancy and lactation

研究者

相似试验

Incidence of symptomatic meibomian gland dysfunction... | 临床试验